Sensex

up-green-arrow

Nifty

up-green-arrow

USDINR

down-red-arrow

GBPINR

down-red-arrow

EURINR

down-red-arrow

Corporate News
Close

Latest News about business and investments.

 
Ajanta Pharma revises share encumbrance details following BSE-noted discrepancies
17-Nov-26 10:49Hrs IST

Ajanta Pharma Limited disclosed revised details regarding encumbrance of shares under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The revision, prompted by a discrepancy noted by the BSE, specifies the names of both the lender and the trustee who may hold shares directly or on behalf of the lender, concerning shares encumbered by Aayush Agrawal Trust. Entities including Gabs Investments Pvt Ltd, Yogesh Agrawal Trust, Rajesh Agrawal Trust, Ravi Agrawal Trust, and Ganga Exports have also created encumbrances on shares of Ajanta Pharma Limited.

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise